A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram

Madhukar H. Trivedi, Andrew J. Cutler, Cynthia Richards, Robert Lasser, Brooke B. Geibel, Joseph Gao, Angelo Sambunaris, Ashwin A. Patkar

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram'. Together they form a unique fingerprint.

Medicine & Life Sciences